Anti-ischemic effect of Nigella sativa L. Seed in male rats

Iranian Journal of Pharmaceutical Research

Volumn 5, Issue 1, 2006, Pages 53-58

  Hosseinzadeh, Hossein ^a   Jaafari, Mahmoud Reza ^a   Khoei, Ali Reza ^b   Rahmani, Massoud ^a  

^a MASHHAD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b MASHHAD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Anti ischemic activity; Four vessel occlusion; Hippocampus; Nigella sativa seed

Indexed keywords

EID: 79251472688     PISSN: 17350328     EISSN: 17266890     Source Type: Journal    
DOI: 10.22037/IJPR.2010.653     Document Type: Article

References (27)

1. Dirnagl U, Iadecola C and Moskowitz MA. Pathobiology of ischemic stroke: an integrated view. Trends Neurosci. (1999) 22: 391-397
2. Jurlink BHJ and Sweeney MI. Mechanisms that result in damage during and following cerebral ischemia. Neurosci. Behav. Rev. (1997) 21: 121-128
3. Patel M, Day BJ, Crapo JD, Fridovich I and McNamara JO. Requirement for superoxide in excitotoxic cell death. Neuron (1996) 16: 345-355
4. Weglicki WB, Dichens BF and Mak JT. Enhanced lysosomal phospholipid degradation and lysophospholipid production due to free radicals. Biochem. Biophys. Res. Commun. (1984) 124: 229-235
5. Abdel-Fattah AM, Matsumoto K and Watanabe H. Antinociceptive effects of Nigella sativa oil and its major component, thymoquinone in mice. Eur. J. Pharmacol. (2000) 400: 89-97
6. Mutabagani A and El-Mahdy SA. Study of the anti-inflammatory activity of Nigella sativa L. and thymoquinone in rats. Saudi Pharm. J. (1997) 5: 110-113
7. Burits M and Bucar F. Antioxidant activity of Nigella sativa essential oil. Phytother. Res. (2000) 14: 323-328
8. Houghton PJ, Zarka R, de las Heras B and Hoult JR. Fixed oil of Nigella sativa and derived thymoquinone inhibit eicosanoid generation in leukocytes and membrane lipid peroxidation. Planta Med. (1995) 61: 33-36
9. Turkdogan MK, Agaoglu Z, Yener Z, Sekeroglu R, Akkan HA and Avci ME. The role of antioxidant vitamins (C and E), selenium and Nigella sativa in the prevention of liver fibrosis and cirrhosis in rabbits: new hopes. Dtsch. Tierarztl. Wochenschr. (2001) 108: 71-73
10. Morsi NM. Antimicrobial effect of crude extracts of Nigella sativa on multiple antibiotics-resistant bacteria. Acta Microbiol. Pol. (2000) 49: 63-74
11. Gilani AH, Aziz N, Khurram IM, Chaudhary KS and Iqbal A. Bronchodilator, spasmolytic and calcium antagonist activities of Nigella sativa seeds (Kalonji): a traditional herbal product with multiple medicinal uses. J. Pak. Med. Assoc. (2001) 51: 115-120
12. Chakravarty N. Inhibition of histamine release from mast cells by nigellone. Ann. Allergy (1993) 70: 237-242
13. El-Abhar HS, Abdallah DM and Saleh S. Gastroprotective activity of Nigella sativa oil and its constituent, thymoquinone, against gastric mucosal injury induced by ischemia/reperfusion in rats. J. Ethnopharmacol. (2003) 84: 251-258
14. Evans WC. Trease and Evans’ Pharmacognosy. Bailliere Tindall Press, London (1983) 309-706
15. Pulsinelli WA and Brierley JB. A new model of bilateral hemispheric ischemia in the unanesthetized rat. Stroke (1979) 10: 267-272
16. Sydserff SG, Cross AJ, Murray TK, Jones JA and Green AR. Clomethiazole is neuroprotective in models of global and focal cerebral ischemia when infused at doses producing clinically relevant plasma concentrations. Brain Res. (2000) 862: 59-62
17. Ahlemeyer B, Junker V, Hühne R and Krieglstein J. Neuroprotective effects of NV-31, a bilobalide-derived compound: evidence for an antioxidative mechanism. Brain Res. (2001) 890: 338-342
18. Largeron M, Mesples B, Gressens P, Cecchelli R and Spedding M. The neuroprotective activity of 8alkylamino-1,4-benzoxazine antioxidants. Eur. J. Pharmacol. (2001) 424: 189-194
19. Arai K, Nishiyama N, Matsuki N and Ikegaya Y. Neuroprotective effects of lipoxygenase inhibitors against ischemic injury in rat hippocampal slice cultures. Brain Res. (2001) 904: 167-172
20. Funato H, Kawano H, Akada Y, Katsuki Y, Sato M and Uemura A. Effects of a calcium antagonist, lacidipine, on experimental focal cerebral ischemia in rats. Jpn. J. Pharmacol. (1997) 75: 415-423
21. Araki T, Kato H and Kogure K. Postischemic alteration of muscarinic acetylcholine and adenosine α-1 binding sites in gerbil brain protective effects of a novel vinca alkaloid derivative vinconate and pentobarbital using an autoradiographic study. Res. Exp. Med. (1992) 192: 79-88
22. Favit A, Sortino M, Aleppo G, Scapagnini U and Canonico P. The inhibition of peroxide formation as a possible substrate for the neuroprotective action of dihydroergocryptine. J. Neural. Transm. Suppl. (1995) 45: 297-305
23. Ghosheh OA, Houdi AA and Crooks PA. High perfonnance liquid chromatographic analysis of the pharmacologically active quinones and related compounds in the oil of the black seed (Nigella sativa L.). J. Pharm. Biomed. Anal. (1999) 19: 757-762
24. Rahman A, Malik S and Zaman K. Nigellimine: a new isoquinoline alkaloid from the seeds of Nigella sativa. J. Nat. Prod. (1992) 55: 676-678
25. Rahman A, Malik S, Hasan SS, Choudhary MI, Ni CZ and Clardy J. Nigellidine, a new indazole alkaloid from the seeds of Nigella sativa. Tetrahedron Lett. (1995) 36: 1993-1996
26. Rao MA, Hatcher JF and Dempsey RJ. Lipid metabolism in ischemic neuronal death. Rec. Res. Dev. Neurochem. (1999) 2: 533-549
27. Wang Q, Xu J, Rottinghaus GE, Simonyi A, Lubahn D, Sun GY and Sun AY. Resveratrol protects against global cerebral ischemic injury in gerbils. Brain Res. (2002) 958: 439-447